Information Provided By: 
Fly News Breaks for May 26, 2015
BLUE
May 26, 2015 | 06:22 EDT
Piper Jaffray analyst Joshua Schimmer raised his price target for bluebird bio shares to $213 from $186 and keeps an Overweight rating on the name. After speaking with management, Schimmer has increased confidence that the company is "well on its way" to curing a "meaningful percent" of Sickle Cell Disease patients. bluebird remains the analyst's top mid-cap pick. The stock closed Friday at $178.38.
News For BLUE From the Last 2 Days
There are no results for your query BLUE
